83 related articles for article (PubMed ID: 2977856)
1. Influence of thromboxane metabolism interference on glycemia regulation in rats.
Nechifor M; Busuioc A; Cocu F
Rev Med Chir Soc Med Nat Iasi; 1988; 92(3):555-7. PubMed ID: 2977856
[No Abstract] [Full Text] [Related]
2. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
Sprague PW; Heikes JE; Harris DN; Greenberg R
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
[No Abstract] [Full Text] [Related]
3. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Vercammen E; Freyne E; Janssen PA
Prog Clin Biol Res; 1989; 301():567-72. PubMed ID: 2529556
[No Abstract] [Full Text] [Related]
4. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane A2 does not play a role in the development or maintenance of hypertension in spontaneously hypertensive rats.
Stegmeier K; Sponer G; Pill J
Prog Clin Biol Res; 1987; 242():253-7. PubMed ID: 2959964
[No Abstract] [Full Text] [Related]
6. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191.
Humphrey PP; Hallet P; Hornby EJ; Wallis CJ; Collington EW; Lumley P
Circulation; 1990 Jan; 81(1 Suppl):I42-52; discussion I59-60. PubMed ID: 2136817
[TBL] [Abstract][Full Text] [Related]
8. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J
Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
[No Abstract] [Full Text] [Related]
9. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
Tobias LD; Hamilton JG
Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
[No Abstract] [Full Text] [Related]
10. Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
Le Breton GC; Lipowski JP; Feinberg H; Venton DL; Ho T; Wu KK
J Pharmacol Exp Ther; 1984 Apr; 229(1):80-4. PubMed ID: 6423815
[TBL] [Abstract][Full Text] [Related]
11. Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. A review.
Fiddler GI; Lumley P
Circulation; 1990 Jan; 81(1 Suppl):I69-78; discussion I79-80. PubMed ID: 2136820
[TBL] [Abstract][Full Text] [Related]
12. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane synthase inhibitors and receptor antagonists.
Vermylen J; Deckmyn H
Cardiovasc Drugs Ther; 1992 Feb; 6(1):29-33. PubMed ID: 1533533
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandins and hemostasis: an overview.
Stuart MJ
Adv Pediatr; 1983; 30():321-64. PubMed ID: 6231843
[No Abstract] [Full Text] [Related]
15. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
[TBL] [Abstract][Full Text] [Related]
16. Researches on the influence of some pharmacological interferences of the metabolism of icosanoids on the glycemia in rats.
Nechifor M; Busuioc A; Cocu F; Costuleanu M; Naghebaner B
Physiologie; 1989; 26(3):213-6. PubMed ID: 2510201
[TBL] [Abstract][Full Text] [Related]
17. Influence of thromboxane receptor-antagonists on the interaction of platelets with solid-phase immobilized human collagen.
Misselwitz F; Hofmann U; Leytin VL; Repin VS
Biomed Biochim Acta; 1987; 46(7):595-8. PubMed ID: 2962573
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis and pharmacological modulation of thromboxane in humans.
Patrono C
Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814
[TBL] [Abstract][Full Text] [Related]
19. [Thromboxane antagonism in thrombocytes--pathophysiology, pharmacology and possible clinical significance].
Schrör K
Wien Klin Wochenschr; 1991; 103(18):543-53. PubMed ID: 1836294
[TBL] [Abstract][Full Text] [Related]
20. Stable carbocyclic analog of thromboxane A2 as antagonist of prostaglandin receptors.
Shimizu K; Kohli JD; Goldberg LI; Kittisopikul S; Fried J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():333-6. PubMed ID: 6303072
[No Abstract] [Full Text] [Related]
[Next] [New Search]
